AstraZeneca spins off autoimmune drugs into new biotech company

AstraZeneca is spinning off six early-stage experimental drugs into a new US$250 million standalone biotech company focused on severe autoimmune diseases.

from Latest News http://ift.tt/2GM6Umj

Comments

Popular posts from this blog

اندرون لاہور: ایک تاریخی اثاثہ

نیشنل ہائی وے پر جعفرآباد سے کوئٹہ تک سفر (آخری حصہ)